<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="evidence" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="cause" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">4. Discussion</segment>
<segment id="2" parent="1002" relname="preparation">The MDS-CVI is primarily a data-collection tool .</segment>
<segment id="3" parent="1003" relname="same_unit">However ,</segment>
<segment id="4" parent="1005" relname="circumstance">when completing the registry ,</segment>
<segment id="5" parent="1006" relname="span">healthcare professionals are reminded of important actions</segment>
<segment id="6" parent="5" relname="elaboration">that can be carried out in people with risk factors such as older age , female sex , and obesity ,</segment>
<segment id="7" parent="1007" relname="span">which increase their likelihood</segment>
<segment id="8" parent="7" relname="elaboration">of having CVD .</segment>
<segment id="9" parent="1010" relname="span">Activities</segment>
<segment id="10" parent="9" relname="purpose">to promote health ,</segment>
<segment id="11" parent="1011" relname="joint">prevent CVD ,</segment>
<segment id="12" parent="1012" relname="span">and diagnose it at earlier stages</segment>
<segment id="13" parent="12" relname="elaboration">will help halt or delay disease progress .</segment>
<segment id="14" parent="1014" relname="span">Healthcare professionals , and those</segment>
<segment id="15" parent="1015" relname="span">working in primary health in particular , should aim to educate at-risk patients</segment>
<segment id="16" parent="1016" relname="joint">to lead a healthy lifestyle</segment>
<segment id="17" parent="1016" relname="joint">and use compression stockings .</segment>
<segment id="18" parent="19" relname="attribution">Due to increased awareness of CVD ,</segment>
<segment id="19" parent="1018" relname="span">the tendency is generally for earlier diagnosis and treatment .</segment>
<segment id="20" parent="1019" relname="joint">However , in some countries , the disease is not detected until more advanced stages .</segment>
<segment id="21" parent="1022" relname="span">There are gaps in healthcare professionals ’ knowledge of venous leg ulcer physiology and its healing process ,</segment>
<segment id="22" parent="21" relname="cause">partly due to a lack of training at a degree level .</segment>
<segment id="23" parent="1023" relname="span">By applying and incorporating this MDS-CVI in patients ’ health records ,</segment>
<segment id="24" parent="23" relname="elaboration">healthcare professionals will find it easier to monitor the disease course at every stage .</segment>
<segment id="25" parent="1025" relname="span">Above all , they should follow the recommendations</segment>
<segment id="26" parent="25" relname="purpose">to ensure correct diagnosis and treatment .</segment>
<segment id="27" parent="1027" relname="span">The CEAP classification system is a very easy method</segment>
<segment id="28" parent="1028" relname="joint">to classify venous disease</segment>
<segment id="29" parent="1028" relname="joint">and reach a reliable diagnosis of CVD/CVI in the population .</segment>
<segment id="30" parent="1030" relname="span">The clinical part of the system can be obtained simply by observing a patient ’s legs in the primary care setting .</segment>
<segment id="31" parent="1032" relname="attribution">It is estimated</segment>
<segment id="32" parent="1033" relname="span">that 80 % of the population have the mildest level of symptoms</segment>
<segment id="33" parent="32" relname="elaboration">( C1 – C2 , spider and varicose veins ) ,</segment>
<segment id="34" parent="1034" relname="span">while 5 % have the most advanced stages</segment>
<segment id="35" parent="34" relname="elaboration">( C3 – C6 ) .</segment>
<segment id="36" parent="1019" relname="joint">Implementation of this evidence-based MDS-CVI would result in more reliable data collection</segment>
<segment id="37" parent="1037" relname="span">and facilitate monitoring of a specific population</segment>
<segment id="38" parent="1038" relname="span">to observe disease progression , the treatments</segment>
<segment id="39" parent="38" relname="elaboration">used , and their effectiveness .</segment>
<segment id="40" parent="1041" relname="span">With the existing level of evidence of the importance of therapeutic compression of the lower limbs ,</segment>
<segment id="41" parent="40" relname="elaboration">it is unacceptable that 90 % of patients with CVI in Turkey and 54 % of patients with venous ulcers in Spain are not given compression stockings .</segment>
<segment id="42" parent="1042" relname="span">The MDS-CVI will also permit health managers to plan interventions</segment>
<segment id="43" parent="1043" relname="joint">according to the venous state of the population</segment>
<segment id="44" parent="1043" relname="joint">and identify which quality indicators should be applied .</segment>
<segment id="45" parent="1019" relname="joint">People with CVI have a poor quality of life .</segment>
<segment id="46" parent="1019" relname="joint">It is therefore important to determine how the venous disease affects each individual .</segment>
<segment id="47" parent="1048" relname="span">Specific instruments are available</segment>
<segment id="48" parent="1049" relname="span">to measure quality of life in these patients , such as the Aberdeen Varicose Vein Questionnaire</segment>
<segment id="49" parent="48" relname="restatement">( AVVQ )</segment>
<segment id="50" parent="1051" relname="span">or the Chronic Venous Insufficiency Quality of Life Questionnaire</segment>
<segment id="51" parent="50" relname="restatement">( CIVIC )</segment>
<segment id="52" parent="1050" relname="same_unit">for patients with CVI , and the Charing Cross Venous Ulcer Questionnaire for patients with venous ulcers .</segment>
<segment id="53" parent="1019" relname="joint">The instruments are valid for only certain languages and cultures</segment>
<segment id="54" parent="1054" relname="span">and they therefore need to be adapted</segment>
<segment id="55" parent="54" relname="purpose">to be effective .</segment>
<segment id="56" parent="1019" relname="joint">Non-pharmacological measures are essential in the prevention and adjuvant therapy of CVD</segment>
<segment id="57" parent="1019" relname="joint">and healthcare professionals should therefore be aware of their existence</segment>
<segment id="58" parent="1019" relname="joint">and use them in their clinical practice .</segment>
<segment id="59" parent="1019" relname="joint">Recommendations such as weight loss or taking regular exercise will help venous return</segment>
<segment id="60" parent="1019" relname="joint">and delay symptom progression .</segment>
<segment id="61" parent="1019" relname="joint">The MDS for CVI establishes minimum quality care criteria</segment>
<segment id="62" parent="1019" relname="joint">and can help to guide in the purchase of necessary services .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="multinuc" parent="1001" relname="span"/>
<group id="1003" type="multinuc" parent="1002" relname="joint"/>
<group id="1004" type="span" parent="1003" relname="same_unit"/>
<group id="1005" type="span" parent="1004" relname="span"/>
<group id="1006" type="span" parent="1005" relname="span"/>
<group id="1007" type="span" parent="1006" relname="elaboration"/>
<group id="1009" type="multinuc" parent="1002" relname="joint"/>
<group id="1010" type="span" parent="1009" relname="same_unit"/>
<group id="1011" type="multinuc" parent="1009" relname="same_unit"/>
<group id="1012" type="span" parent="1011" relname="joint"/>
<group id="1014" type="span" parent="1002" relname="joint"/>
<group id="1015" type="span" parent="14" relname="elaboration"/>
<group id="1016" type="multinuc" parent="15" relname="purpose"/>
<group id="1017" type="multinuc" parent="1002" relname="joint"/>
<group id="1018" type="span" parent="1017" relname="contrast"/>
<group id="1019" type="multinuc" parent="1017" relname="contrast"/>
<group id="1021" type="span" parent="1019" relname="joint"/>
<group id="1022" type="span" parent="1021" relname="span"/>
<group id="1023" type="span" parent="1022" relname="means"/>
<group id="1025" type="span" parent="1019" relname="joint"/>
<group id="1027" type="span" parent="1019" relname="joint"/>
<group id="1028" type="multinuc" parent="27" relname="purpose"/>
<group id="1030" type="span" parent="1019" relname="joint"/>
<group id="1031" type="span" parent="30" relname="elaboration"/>
<group id="1032" type="span" parent="1031" relname="span"/>
<group id="1033" type="span" parent="1032" relname="span"/>
<group id="1034" type="span" parent="1033" relname="evidence"/>
<group id="1037" type="span" parent="1019" relname="joint"/>
<group id="1038" type="span" parent="37" relname="purpose"/>
<group id="1040" type="span" parent="1019" relname="joint"/>
<group id="1041" type="span" parent="1040" relname="span"/>
<group id="1042" type="span" parent="1041" relname="elaboration"/>
<group id="1043" type="multinuc" parent="42" relname="attribution"/>
<group id="1047" type="multinuc" parent="1019" relname="joint"/>
<group id="1048" type="span" parent="1047" relname="same_unit"/>
<group id="1049" type="span" parent="47" relname="purpose"/>
<group id="1050" type="multinuc" parent="1047" relname="same_unit"/>
<group id="1051" type="span" parent="1050" relname="same_unit"/>
<group id="1054" type="span" parent="1019" relname="joint"/>
	</body>
</rst>
